U0003 HCPCS code: Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
U0003 is the HCPCS Level II code for infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r. CMS terminated U0003 on 2023-05-11; do not bill it for later dates of service. In 2023 Medicare paid an average of $73.47 per service for U0003 across 1,301,164 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume fell 80% from 2022 to 2023 (6,668,388 to 1,301,164 services). In 2023, about 3,950 clinicians billed Medicare for U0003 for 554,612 beneficiaries; California, Illinois, New Jersey accounted for 68% of services.
Code details
| Field | Value |
|---|---|
| Section | U codes — Coronavirus diagnostic panel / laboratory |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 22 |
| BETOS category | T1H |
| Added | 2020-04-14 |
| Last action effective | 2023-05-12 |
| Terminated | 2023-05-11 |
Who bills U0003 (2023)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,950 |
| Medicare beneficiaries | 554,612 |
| States with claims | 51 |
| Share of services in top 3 states (California, Illinois, New Jersey) | 68% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for U0003, 2022–2023
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 6,668,388 | 2,488,445 | $74.16 | $74.16 |
| 2023 | 1,301,164 | 554,612 | $73.47 | $73.47 |
States with the most U0003 services (2023)
| State | Services | Avg. paid |
|---|---|---|
| California | 446,240 | $73.49 |
| Illinois | 329,704 | $73.49 |
| New Jersey | 105,772 | $73.43 |
| North Carolina | 88,546 | $73.50 |
| Texas | 56,743 | $73.42 |
What changed for U0003
- 2020-04-14: U0003 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code U0003?
U0003 is the HCPCS Level II code for infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r. Short descriptor: "Cov-19 amp prb hgh thruput".
How much does Medicare pay for U0003?
In 2023, the average Medicare payment was $73.47 per service (average allowed $73.47).
Does Medicare cover U0003?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related U00 codes
- U0001 — Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel
- U0002 — 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc
- U0004 — 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
- U0005 — Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under U0003
- Watch U0003 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for U0003
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.